Literature DB >> 9725468

Pharmacokinetic examination of antipyrine passage through the placenta and the small intestine in rats.

F Staud1, Z Fendrich, O Jindrová.   

Abstract

The placental and small intestinal barriers, though obviously different, show many functional as well as morphological similarities. When the surface area of both barriers in man was recalculated to a unit of body weight, nearly identical values (2.71 and 2.86 m2/kg of body mass, respectively) were obtained. The aims of the present study were (1) to compare mutual permeability of these two barriers to antipyrine (AP), and (2) to describe pharmacokinetics of AP in pregnant and non-pregnant rats. In placental studies AP showed that its rapid transfer through the placenta (k(tr) = 0.046 min(-1)) was governed by the mechanism of passive diffusion. In the closed circuit, FMCR(eq) was 1.085, t(eq) was 112.10 min and k(eq) was 0.020 min(-1). Absorptive studies performed on the rat small intestine indicated an identical mechanism of drug transport. The apparent first-order absorption rate constant of AP was 0.479 min(-1), and Tmax was 8.95 minutes. Differences in AP pharmacokinetics between pregnant and non-pregnant rats were significant during the distribution phase (t(1/2) = 3.78 and 5.87 min, respectively), whereas the elimination phase was unaffected. AP has been demonstrated, as expected, to be an excellent marker for drug transport studies through different body barriers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725468     DOI: 10.1007/BF03189326

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  12 in total

Review 1.  Placental transport function.

Authors:  H Schneider
Journal:  Reprod Fertil Dev       Date:  1991       Impact factor: 2.311

Review 2.  In vitro systems for studying intestinal drug absorption.

Authors:  K M Hillgren; A Kato; R T Borchardt
Journal:  Med Res Rev       Date:  1995-03       Impact factor: 12.944

3.  [Specific method for the determination of phenazon in biological fluids (author's transl)].

Authors:  H J Brinkmann; J H Hengstmann
Journal:  Arzneimittelforschung       Date:  1976-04

Review 4.  Drug kinetics in pregnancy.

Authors:  B Krauer; F Krauer
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

5.  Evidence for active maternal-fetal transport of Na+ across the placenta of the anaesthetized rat.

Authors:  J Stulc; B Stulcová; C P Sibley
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

6.  Placental transfer of theophylline in an in vitro closed perfusion system of human placenta isolated lobule.

Authors:  D Omarini; M M Barzago; A Bortolotti; G Lucchini; F Stellari; S Efrati; M Bonati
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Oct-Dec       Impact factor: 2.441

7.  Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics.

Authors:  J W Paxton
Journal:  N Z Med J       Date:  1981-12-09

Review 8.  Drug treatment in pregnancy.

Authors:  H Schneider
Journal:  Curr Opin Obstet Gynecol       Date:  1994-02       Impact factor: 1.927

9.  Mefloquine transfer during in vitro human placenta perfusion.

Authors:  M M Barzago; D Omarini; A Bortolotti; F F Stellari; G Lucchini; S Efrati; M Bonati
Journal:  J Pharmacol Exp Ther       Date:  1994-04       Impact factor: 4.030

Review 10.  Drug transfer across the placenta. Considerations in treatment and research.

Authors:  C Simone; L O Derewlany; G Koren
Journal:  Clin Perinatol       Date:  1994-09       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.